TORONTO, Sept. 16, 2022 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning hashish merchandise is happy to announce the appointment of James Afara because the Company’s Chief Operating Officer (COO).
A results-driven chief with an distinctive observe report, James brings over 15 years of operations and provide chain expertise to Entourage, serving most not too long ago as its Senior Vice President of Strategic Sourcing, Quality Assurance and Cultivation. His promotion comes at a pivotal time because the Company integrates all practical groups in cultivation, tissue tradition, manufacturing, operations and provide chain underneath one chief, to align core competencies and sources for optimum output.
“Our commercial success will always be driven by our ability to scale production of our award-winning Color Cannabis, Saturday and Starseed Medicinal products. Over the past few months, James has demonstrated operational excellence in building disciplined strategies to meet our aggressive sales demand, while leading a team that consistently executes to plan,” stated George Scorsis, CEO and Executive Chairman. “With his proven track record, business acumen and strong management outlook, James is perfectly suited to oversee all functions related to bringing saleable products to market, from seed to sale – straight through to distribution. With the addition of James, we have solidified and further strengthened our management team that will be pivotal to meeting our revenue and profitability goals in the near term.”
James Afara, Chief Operating Officer, added: “Entourage has an excellent reputation for producing top-shelf flower and innovative products, as well as consistently meeting fulfilment and delivery commitments. I’m proud to be expanding my mandate alongside this industry’s top professionals – and leading the very best cultivation and operations team in the business. We are already noting positive results and driving value – the benefits of which will eventually be passed along to our consumers, patients and shareholders.”
Prior to becoming a member of Entourage in late 2021, James served because the COO at CannTx Life Sciences. An expert engineer by commerce, James is widely known for his business analytics methods that helped commercialize proprietary tissue tradition remediation providers and introduced ahead automated-operations actions for hashish produced each in small batches and at scale. Over the previous 15 years, James held manufacturing-related management roles of elevated obligations at SteriPro Canada and Maple Leaf Foods. James holds a Bachelor of Science, Biochemical Engineering Degree from Western University and has additionally accomplished Leadership Certification programs from the Ivy School of Business.
Mr. Scorsis concluded: “On behalf of the Entourage team, I’d also like to acknowledge and whole-heartedly thank Jeff Keyes, SVP of Operations, for his dedication to optimizing our operations over the past three years. Under Jeff’s watch, our provincial partners applauded Entourage for its stellar production record, routinely naming the Company as a top performer and shining example of efficiency and operational excellence. Jeff recently advised he was stepping down to pursue a manufacturing-focused role outside of the Company. We wish Jeff all the best in his new pursuits and will always be indebted to him, for his contributions to our success.”
Visit Entourage’s web site right here to entry the newest Company updates.
About Entourage Health Corp.
Entourage Health Corp. is the publicly traded guardian Company of Entourage Brands Corp. (previously WeedMD RX Inc.) and CannTx Life Sciences Inc., licence holders producing and distributing hashish merchandise for each the medical and adult-use markets. The Company owns and operates a state-of-the-art hybrid greenhouse and processing facility situated on 158-acres in Strathroy, ON; a completely licensed 26,000 sq. ft. Aylmer, ON processing facility, specializing in hashish extraction; and a micropropagation, tissue tradition and genetics centre-of-excellence in Guelph, Ontario. With its Starseed Medicinal medical-centric model, Entourage has expanded its multi-channeled distribution technique. Starseed’s industry-first, unique partnership with LiUNA, the biggest building union in Canada, together with employers and over 10 union teams enhances Entourage’s direct gross sales to medical sufferers. Entourage’s elite adult-use product portfolio consists of Color Cannabis, Saturday Cannabis and Royal City Cannabis Co.– offered throughout eight provincial distribution companies. It is the unique Canadian producer and distributor of award-winning U.S.-based wellness model Mary’s Medicinals offered in each medical and adult-use channels. Under a collaboration with The Boston Beer Company subsidiary, Entourage can also be the unique distributor of cannabis-infused drinks ‘TeaPot’ in Canada, which launched in choose provinces in summer season 2022.
For extra data, please go to us at www.entouragehealthcorp.com
Follow Entourage and its manufacturers on LinkedIn
Twitter: Entourage, Color Cannabis, Saturday Cannabis, Starseed & Royal City Cannabis Co.
Instagram: Entourage, Color Cannabis, Saturday Cannabis, Starseed & Royal City Cannabis Co.
For additional data, investor or media inquiries, please contact:
Marianella delaBarrera
SVP, Communications & Corporate Affairs
416-897-6644
[email protected]
[email protected]
[email protected]
Forward Looking Information This press launch comprises “forward-looking information” inside the which means of relevant Canadian securities laws that are primarily based upon Entourage’s present inside expectations, estimates, projections, assumptions and beliefs and views of future occasions. Forward-looking data could be recognized by way of forward-looking terminology equivalent to “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and different related phrases, together with unfavorable and grammatical variations thereof, or statements that sure occasions or circumstances “may”, “would” or “will” occur, or by discussions of technique.
The forward-looking data on this information launch relies upon the expectations, estimates, projections, assumptions and views of future occasions which administration believes to be cheap within the circumstances. Forward-looking data consists of estimates, plans, expectations, opinions, forecasts, projections, targets, steerage or different statements that aren’t statements of truth. Forward-looking data essentially contain recognized and unknown dangers, together with, with out limitation, dangers related to normal financial circumstances; antagonistic {industry} occasions; lack of markets; future legislative and regulatory developments; lack of ability to entry ample capital from inside and exterior sources, and/or lack of ability to entry ample capital on beneficial phrases; the hashish {industry} in Canada typically; the power of Entourage to implement its business methods; the COVID-19 pandemic; competitors; crop failure; and different dangers.
Any forward-looking data speaks solely as of the date on which it’s made, and, besides as required by legislation, Entourage doesn’t undertake any obligation to replace or revise any forward-looking data, whether or not because of new data, future occasions or in any other case. New components emerge from time to time, and it’s not doable for Entourage to predict all such components. When contemplating this forward-looking data, readers ought to be mindful the chance components and different cautionary statements in Entourage’s disclosure paperwork filed with the relevant Canadian securities regulatory authorities on SEDAR at www.sedar.com. The danger components and different components famous within the disclosure paperwork may trigger precise occasions or outcomes to differ materially from these described in any forward-looking data.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE
